Oxitec Revenue and Competitors

Abingdon,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Oxitec's estimated annual revenue is currently $33.3M per year.(i)
  • Oxitec's estimated revenue per employee is $155,000

Employee Data

  • Oxitec has 215 Employees.(i)
  • Oxitec grew their employee count by 0% last year.

Oxitec's People

NameTitleEmail/Phone
1
Head Global Public AffairsReveal Email/Phone
2
Head ResearchReveal Email/Phone
3
Head Malaria ProgramsReveal Email/Phone
4
Head Data ManagementReveal Email/Phone
5
Head Agricultural Product DevelopmentReveal Email/Phone
6
Head DevelopmentReveal Email/Phone
7
Head Product Development, Public HealthReveal Email/Phone
8
Director U.S. ProgramsReveal Email/Phone
9
Chief Technology OfficerReveal Email/Phone
10
Chief Financial OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is Oxitec?

Oxitec is a team of passionate individuals from 15 countries improving lives and livelihoods by developing the world's first safe, self-limiting insect technology to control insects that transmit diseases and destroy crops. Our technology platform allows us to build safe, non-toxic, species-specific, and self-limiting control solutions to a range of damaging insects. We work in close partnerships with governments, foundations, companies and communities around the world and have demonstrated excellence in targeted insect suppression, biosafety, environmental sustainability, regulatory approvals, public acceptance, and scalability. We are growing, so people who share our desire to have impact globally are encouraged to get in touch.

keywords:N/A

N/A

Total Funding

215

Number of Employees

$33.3M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Oxitec News

2022-04-17 - First U.S. Open-Air Test of Genetically Modified Mosquitoes ...

Biotech firm Oxitec engineered the bugs in an effort to curb their numbers and help stop the spread of disease. Sarah Kuta.

2022-04-17 - First U.S. trial of genetically modified mosquitoes deemed ...

Biotechnology firm Oxitec has successfully tested releasing genetically modified Aedes aegypti mosquitoes in the Florida Keys. Adam Hunt.

2022-04-17 - Biotech company announces results from first US trial of GM ...

Oxitec, which developed the insects, released nearly five million engineered Aedes aegypti mosquitoes over the course of seven months, and has...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$24.4M2227%N/A
#2
$67.4M227-3%N/A
#3
$62.3M2319%N/A
#4
$77M244N/AN/A
#5
$48.7M2469%N/A